Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional study.
about
Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Post-marketing research and it ...... 2010: A cross-sectional study.
@en
Post-marketing research and it ...... 2010: A cross-sectional study.
@nl
type
label
Post-marketing research and it ...... 2010: A cross-sectional study.
@en
Post-marketing research and it ...... 2010: A cross-sectional study.
@nl
prefLabel
Post-marketing research and it ...... 2010: A cross-sectional study.
@en
Post-marketing research and it ...... 2010: A cross-sectional study.
@nl
P2860
P50
P356
P1476
Post-marketing research and it ...... 2010: A cross-sectional study
@en
P2093
Gabriel Baron
Nicholas S Downing
P2860
P304
P356
10.1002/IJC.31061
P577
2017-10-12T00:00:00Z